Compounds and therapy for resisting memory loss in humans
US6159986A · kind A · utility
2Cited by
12References
19Claims
0Family size
Inventor
Key dates
| Filing date | Nov 2, 1999 |
| Grant date | Dec 12, 2000 |
| Priority date | — |
| Expiry date | Nov 2, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/47
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Therapies and compounds for the inhibition of memory loss. In one embodiment, a combination of Huperzine A and hypericin is employed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.